Related Experiment Video
Updated: Feb 8, 2026

Chronic Social Defeat Stress in Early Adolescent Male Mice
Published on: January 24, 2025
Opioid Prescribing to Adolescents in the United States From 2005 to 2016
Rachel Mosher Henke1, Ali Bonakdar Tehrani1, Mir M Ali1
1Dr. Henke, Dr. Tehrani, and Dr. O'Brien are with IBM Watson Health, Cambridge, Massachusetts. Dr. Ali and Dr. Mutter are with the Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville, Maryland. Dr. Mazer-Amirshahi is with MedStar Washington Hospital Center, Washington, D.C. Dr. Mark is with RTI International, Rockville.
Objective:
This study assessed trends in days' supply for opioid prescriptions filled by adolescents with commercial insurance and Medicaid.
Methods:
IBM MarketScan commercial and Medicaid pharmacy claims data were used to measure days' supply among adolescents (2005-2016) and to determine whether there were differences between patients with commercial insurance or Medicaid coverage.
Results:
The 2-3 days' supply decreased from 50.5% (2005) to 36.7% of fills (2016), while 4-5 days' supply increased from 30.2% to 37.7%. Fills of 6-7 and 8-15 days increased slightly. Fills of over 30 days remained near 0.0%, and one-day fills remained at 1.0-2.0% until 2016, when they increased to 3.6% Conclusions: For adolescents, fills of prescription opioids generally exceeded three days. Efforts to reduce opioid prescribing through guidelines, prescription drug monitoring programs, and limits on days' supply do not appear to have affected prescribing for adolescents as much as desired.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
Cognitive Development During Adolescence
Measurement: Standard Units
Measurement: Derived Units
Opioid Analgesics: Morphine and Other Natural Cogeners

